{
  "document_id": "HOUSE_OVERSIGHT_028416",
  "filename": "IMAGES-009-HOUSE_OVERSIGHT_028416.txt",
  "text": "i\"}, {\"range™: {\"length\":394,\"start\":0},\"textStyle\":\"_ anf-ts-1\"}],\"layout\":\"default-—\nbody\", \"role\": \"body\", \"text\":\"An examination of Celgened€™s aggressive promotion of\nRevlimid and its predecessor, Thalomid, while Mr. Hugin was a top executive at the\ncompany, including its chief executive for six years, reveals many of the controversial\nfinancial and legal tactics that have tarnished the industryd€™s reputation, from\nmarketing drugs for unapproved uses to raising prices and fighting off generic\ncompetitors.\", \"type\": \"text\"}, {(\"additions\": [{\"URL\":\"https://www.nytimes.com/2017/07/25/h\nealth/celgene-to-pay-280-million-to-settle-fraud-suit-over-cancer\ndrugs.html?partner=applenewsé&ad\n\nkeywords=APPLEMOBILE&region=written throughé&asset_id=100000006090758\", \"range™: {\"length\"\n793, \"Start\":19}, \"type\"? \"Link\" }],\"identifier\":\" ant-body—\n\n12\", \"inlineTextStyles\":[{\"range\":{\"length\":362,\"start\":0},\"textStyle\":\" anf-ts-\n\nim}, {\"range\":{\"Llength\":362,\"start\":0},\"textStyle\":\" anf-ts-1\"}],\"layout\":\"default-\n\nbody\", \"role\":\"body\", \"text\":\"Last year, Celgene paid $280 million to settle a whistle-\nblower lawsuit claiming it had inappropriately promoted Revlimid and Thalomid to treat\na range of cancers beyond what the Food and Drug Administration had approved. Several\ngeneric drug companies have sued the company claiming that Celgene denied them access\nto drug samples needed to make cheaper\ncopies.\",\"type™:\"text\"}, {\"additions\": [{\"URL\":\"https://www. youtube.com/watch?v=RIfsé6hthw\n\nGo\", \"range\": {\"length\":71, \"start \":138},\"type\":\"Link\"}],\"identifier\":\" anf-body-\n13\",\"inlineTextStyles\": [{\"range\":{\"length\":334,\"start\":0},\"textStyle\":\" anf-ts-\nI\"}, {\"range™: {\"length\":334,\"start\":0},\"textStyle\":\" anf-ts-1\"}],\"layout\":\"default-\n\nbody\", \"role\":\"body\", \"text\":\"Mr. Hugin has also been targeted by a super PAC run by a\ncancer patient taking Revlimid that launched a $1.5 million advertising campaign\ncriticizing steep price hikes of cancer drugs during Mr. Hugind€™s tenure at Celgen\nAnd the Menendez campaign has attacked him around drug prices, personal profits and the\n\n$280 million settlement.\",\"type\":\"text\"}, {\"bannerType\":\"any\",\"identifier\":\" anf-\nbanner advertisement-2\",\"layout\": \"ComponentLayout—\n\n4\",\"role\":\"banner advertisement\", \"type\":\"banner advertisement\"}, {\"identifier\"™:\" anf-\nbody-14\", \"inlineTextStyles\": [{\"range\"™:{\"length\":38,\"start\":0},\"textStyle\":\" anf-ts-\nI\"}, {\"range™: {\"length\":38,\"start\":0},\"textStyle\":\" anf-ts-1\"}],\"layout\":\"default—\nbody\", \"role\":\"body\", \"text\":\"Mr. Hugin has dismissed the\n\ncriticism.\",\"type\":\"text\"}, {\"identifier\":\" anf-body-\n15\",\"inlineTextStyles\":[{\"range\":{\"length\":317,\"start\":0},\"textStyle\":\" anf-ts-\n\ni\"}, {\"range\"™:{\"length\":317,\"start\":0},\"textStyle\":\" anf-ts-1\"}],\"layout\":\"default-—\nbody\", \"role\": \"body\", \"text\": \"a€eNew Jersey voters are a lot smarter than my opponent\n\ngives them credit for,d4€ Mr. Hugin said in a statement. A4€eThey understand that it\ncosts billions of dollars in research and development, and years of hard work by\nhundreds of researchers and scientists, to develop medicines that successfully treat\n\nand cure cancer.a€\",\"type\":\"text\"}, {\"identifier\":\" anf-body-\n\n16\", \"inlineTextStyles\":[{\"range\":{\"length\":237,\"start\":0},\"textStyle\":\" anf-ts-\n\nI\"}, {\"range™: {\"length\":237,\"start\":0},\"textStyle\":\"_anf-ts-1\"}],\"layout\":\"default-—\nbody\", \"role\":\"body\", \"text\":\"Some experts are not so sure. Patrick Murray, director of\n\nthe Monmouth University Poll, noted that despite the fact that many large drug\ncompanies are based in New Jersey, public opinion in the state likely mirrors the\n\nnational attitude.\",\"type\"™:\"text\"}, {\"identifier\":\" anf-body-\n17\",\"inlineTextStyles\": [{\"range\":{\"length\":228,\"start\":0},\"textStyle\":\" anf-ts-\ni\"}, {\"range\"™: {\"length\":228,\"start\":0},\"textStyle\":\" anf-ts-1\"}],\"layout\":\"default-\n\nbody\", \"role\": \"body\", \"text\": \"a€eConcern about being able to afford health care is the\ntop issue mentioned by voters in our polling for this yeara€™s midterm, in large part\nbecause of rising drug costs,a4€ Mr. Murray said. d€eThis provides an opening for\nMenendez. ae™mae™\", \"type™:\"text\"}, {\"components\": [{\"caption\":\"Mr. Menendez has attacked\nMr. Hugind€™s record as a pharmaceutical executive, accusing him of profiting from\nmajor price increases for cancer drugs. Bryan Anselm for The New York\n\nTimes\", \"captionComponent\":{\"text\":\"Mr. Menendez has attacked Mr. Hugind€™s record as a\npharmaceutical executive, accusing him of profiting from major price increases for\ncancer drugs. Bryan Anselm for The New York\n\nTimes\"},\"identifier™:\"100000006098032 Sba8b804lidfc\", \"imageIdentifier\":\"5e5526aaedbd7aft\n8c8bhade0a70blidad\", \"layout\":\"fullbleed-\n\nimage\", \"role\":\"photo\", \"type\": \"scalable image\"}, {\"identifier\":\" anf-caption-\n2\",\"inlineTextStyles\": [{\"range\": {\"length\":36, \"start\":146}, \"textStyle\": \"photo-\ncredit\"}],\"layout\":\"default-caption\", \"role\": \"caption\", \"text\":\"Mr. Menendez has attacked\n\nMr. Hugind€™s record as a pharmaceutical executive, accusing him of profiting from\nmajor price increases for cancer drugs. Bryan Anselm for The New York Times\n\n\",\"type™:\"text\"}],\"identifier\":\" anf-container-1\", \"layout\": \"image-\ncontainer\", \"role\":\"container\", \"type\":\"container\"}, {\"identifier\":\" anf-body-\n18\",\"inlineTextStyles\":[{\"range\":{\"length\":277,\"start\":0},\"textStyle\":\" anf-ts-\n\nHOUSE_OVERSIGHT_028416",
  "metadata": {
    "original_filename": "IMAGES-009-HOUSE_OVERSIGHT_028416.txt",
    "source_dataset": "huggingface:tensonaut/EPSTEIN_FILES_20K",
    "character_count": 5332,
    "word_count": 531,
    "line_count": 91,
    "import_date": "2025-11-19T21:47:46.312013",
    "prefix": "IMAGES-009"
  }
}